These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31771828)

  • 1. Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain.
    Takasaki I; Ogashi H; Okada T; Shimodaira A; Hayakawa D; Watanabe A; Miyata A; Kurihara T; Gouda H; Toyooka N
    Eur J Med Chem; 2020 Jan; 186():111902. PubMed ID: 31771828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Screening Identified Novel Small-molecule Antagonists of PAC1 Receptor.
    Takasaki I; Watanabe A; Yokai M; Watanabe Y; Hayakawa D; Nagashima R; Fukuchi M; Okada T; Toyooka N; Miyata A; Gouda H; Kurihara T
    J Pharmacol Exp Ther; 2018 Apr; 365(1):1-8. PubMed ID: 29363578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist.
    Takasaki I; Watanabe A; Okada T; Kanayama D; Nagashima R; Shudo M; Shimodaira A; Nunomura K; Lin B; Watanabe Y; Gouda H; Miyata A; Kurihara T; Toyooka N
    Eur J Med Chem; 2022 Mar; 231():114160. PubMed ID: 35124531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states.
    Davis-Taber R; Baker S; Lehto SG; Zhong C; Surowy CS; Faltynek CR; Scott VE; Honore P
    J Pain; 2008 May; 9(5):449-56. PubMed ID: 18337184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel small-molecule antagonist of PAC1 receptor attenuates formalin-induced inflammatory pain behaviors in mice.
    Takasaki I; Nakamura K; Shimodaira A; Watanabe A; Du Nguyen H; Okada T; Toyooka N; Miyata A; Kurihara T
    J Pharmacol Sci; 2019 Feb; 139(2):129-132. PubMed ID: 30552012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice.
    Yokai M; Kurihara T; Miyata A
    Mol Pain; 2016; 12():. PubMed ID: 27175011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.
    Liao C; de Molliens MP; Schneebeli ST; Brewer M; Song G; Chatenet D; Braas KM; May V; Li J
    Curr Top Med Chem; 2019; 19(16):1399-1417. PubMed ID: 31284862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.
    Missig G; Mei L; Vizzard MA; Braas KM; Waschek JA; Ressler KJ; Hammack SE; May V
    Biol Psychiatry; 2017 Apr; 81(8):671-682. PubMed ID: 28057459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and SAR of hydrazide antagonists of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor type 1 (PAC1-R).
    Beebe X; Darczak D; Davis-Taber RA; Uchic ME; Scott VE; Jarvis MF; Stewart AO
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2162-6. PubMed ID: 18272364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.
    Bourgault S; Vaudry D; Ségalas-Milazzo I; Guilhaudis L; Couvineau A; Laburthe M; Vaudry H; Fournier A
    J Med Chem; 2009 May; 52(10):3308-16. PubMed ID: 19413310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
    Yu R; Zheng L; Cui Y; Zhang H; Ye H
    Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide type 1 receptor signaling evokes long-lasting nociceptive behaviors through the activation of spinal astrocytes in mice.
    Ohnou T; Yokai M; Kurihara T; Hasegawa-Moriyama M; Shimizu T; Inoue K; Kambe Y; Kanmura Y; Miyata A
    J Pharmacol Sci; 2016 Apr; 130(4):194-203. PubMed ID: 26948958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy.
    Dickinson T; Mitchell R; Robberecht P; Fleetwood-Walker SM
    Neuropharmacology; 1999 Jan; 38(1):167-80. PubMed ID: 10193908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
    Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
    Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired somatodendritic responses to pituitary adenylate cyclase-activating polypeptide (PACAP) of supraoptic neurones in PACAP type I -receptor deficient mice.
    Jamen F; Alonso G; Shibuya I; Widmer H; Vacher CM; Calas A; Bockaert J; Brabet P; Dayanithi G
    J Neuroendocrinol; 2003 Sep; 15(9):871-81. PubMed ID: 12899682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
    Martínez C; Juarranz Y; Abad C; Arranz A; Miguel BG; Rosignoli F; Leceta J; Gomariz RP
    J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PACAP and PAC1 receptor in brain development and behavior.
    Shen S; Gehlert DR; Collier DA
    Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.